Anamorelin 50mg 50mg | Purity Not Available
Adooq Bioscience
Anamorelin is currently under development for the management of non-small lung cancer associated cachexia/anorexia.
More Information Supplier PageSearch Results
Anamorelin 5mg 5mg | Purity Not Available
Adooq Bioscience
Anamorelin is currently under development for the management of non-small lung cancer associated cachexia/anorexia.
More Information Supplier PageAnamorelin 25mg 25mg | Purity Not Available
Adooq Bioscience
Anamorelin is currently under development for the management of non-small lung cancer associated cachexia/anorexia.
More Information Supplier PageGSK 269962 50mg 50mg | Purity Not Available
Adooq Bioscience
GSK 269962 is a potent Rho kinase (ROCK) inhibitor (IC50 values are 1.6 and 4 nM for recombinant human ROCK1 and ROCK2 respectively).
More Information Supplier PageAmpalex (CX-516) 100mg 100mg | Purity Not Available
Adooq Bioscience
Ampalex is an ampakine and nootropic that acts as an AMPA receptor positive allosteric modulator
More Information Supplier PageDesmopressin 25mg 25mg | Purity Not Available
Adooq Bioscience
Desmopressin is a synthetic vasopressin analog that acts as an agonist at V1B and V2 receptors (EC50 values are 11.4 and 23.9 nM and Ki values are 5.84 and 65.9 nM respectively).
More Information Supplier PageDesmopressin 2mg 2mg | Purity Not Available
Adooq Bioscience
Desmopressin is a synthetic vasopressin analog that acts as an agonist at V1B and V2 receptors (EC50 values are 11.4 and 23.9 nM and Ki values are 5.84 and 65.9 nM respectively).
More Information Supplier PageOzarelix 5mg 5mg | Purity Not Available
Adooq Bioscience
Ozarelix is a fourth generation GnRH antagonist, induces apoptosis in hormone refractory androgen receptor negative prostate cancer cells modulating expression and activity of death receptors.
More Information Supplier PageOzarelix 2mg 2mg | Purity Not Available
Adooq Bioscience
Ozarelix is a fourth generation GnRH antagonist, induces apoptosis in hormone refractory androgen receptor negative prostate cancer cells modulating expression and activity of death receptors.
More Information Supplier PageOzarelix 10mg 10mg | Purity Not Available
Adooq Bioscience
Ozarelix is a fourth generation GnRH antagonist, induces apoptosis in hormone refractory androgen receptor negative prostate cancer cells modulating expression and activity of death receptors.
More Information Supplier Page